Reuters logo
AstraZeneca, Cephalon to pay to resolve Medicaid allegations: U.S.
July 6, 2015 / 9:46 PM / 2 years ago

AstraZeneca, Cephalon to pay to resolve Medicaid allegations: U.S.

WASHINGTON (Reuters) - AstraZeneca LP has agreed to pay $46.5 million and Cephalon Inc [TEVAE.UL] $7.5 million to resolve allegations that the two drug companies underpaid rebates owed under the Medicaid program, the U.S. Justice Department said on Monday.

A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble

Reporting by Eric Beech; Editing by Bill Trott

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below